Market Place
Sourcing Support
Cipla USA Recalls Nilotinib Capsules Over Manufacturing Issue
09 Mar 2026 //
ECONOMICTIMES
Sun Pharma, Cipla Recall U.S. Products Over Manufacturing Issues
26 Jan 2026 //
ECONOMICTIMES
FDA Observation to Hit Lanreotide supply; Cipla may face earnings
16 Jan 2026 //
BUSINESS STD
Cipla`s plant gets single FDA observation after cGMP inspection
30 May 2025 //
CNBCTV
Cipla Goa facility receives form 483 with 1 observation
21 Jan 2025 //
ECONOMICTIMES
Cipla gets 8 observations after FDA inspection at Bengaluru plant
13 Nov 2024 //
CNBCTV
USFDA issues Form 483 with 1 inspectional observation to Cipla`s Kurkumbh unit
08 May 2024 //
ECONOMICTIMES
Cipla and Glenmark initiate recall of certain products in the US
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
US FDA`s 6 observations for Cipla`s Patalganga unit drags shares down 1.5%
04 Apr 2024 //
CONTRACT PHARMA
Cipla unit recalls anti-seizure drug because of faulty packaging
12 Dec 2023 //
FIERCE PHARMA
Cipla unit recalls one lot of medication in US due to seal integrity issue
10 Dec 2023 //
ECONOMIC TIMES
USFDA warns Cipla for lapses in manufacturing practices at Pithampur facility
20 Nov 2023 //
ECONOMIC TIMES
Cipla shares trade down after FDA inspection at US facility
12 Oct 2023 //
MONEY CONTROL
Cipla falls after US subsidiary receives 5 observations from FDA
21 Sep 2023 //
MONEYCONTROL
Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate
06 Jul 2023 //
PR NEWSWIRE
Cipla`s Pithampur unit gets 8 observations from USFDA after inspection
18 Feb 2023 //
ECONOMIC TIMES
U.S. FDA designates Cipla’s Goa plant as ‘Official Action Indicated’
24 Nov 2022 //
THEHINDU
Another Cipla site lands a Form 483 over cleaning issues and QC controls
23 Sep 2022 //
ENDPTS
U.S. FDA Flags Operational, Procedural Lapses At Cipla’s Goa Unit
20 Sep 2022 //
BQNEWS
Cipla`s Indore plant gets two USFDA observations
05 Jul 2022 //
BUSINESS STANDARD
Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
10 Jan 2021 //
INDIATIMES
FDA hits Cipla with warning letter for sterile injectables plant
18 Mar 2020 //
FIERCE PHARMA
Cipla gets FDA warning letter for cleanliness issues
06 Mar 2020 //
FIERCE PHARMA
Cipla receives warning letter from USFDA, shares fall
26 Feb 2020 //
BUSINESS STANDARD
Cipla receives EIR from US FDA for Invagen manufacturing facility
29 Jan 2020 //
PHARMABIZ
Dr Reddy`s Laboratories, Cipla arm recall drugs from American market
29 Apr 2019 //
BUSINESS-STANDARD
Cipla recalls 4,800 bottles of anti-HIV tablets from US
31 Dec 2018 //
ECONOMIC TIMES
Imatinib 400mg Capsules (3 x 10) PL 36390/0180 : Company-led recall
22 Sep 2018 //
GOV-UK
Dr Reddy`s recalls 3.25 lakh cartons Cipla-made acne drug from US
14 Jun 2017 //
ECONOMIC TIMES
NPPA`s drug overcharging penalty at a record high
11 Mar 2017 //
BUSINESS STANDARD
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Another US warning on Indian drugs
25 Feb 2017 //
BUSINESS STANDARD
634 drugs suspected to be not compliant with government price ceiling
24 Feb 2017 //
NEW INDIAN EXPRESS
Cipla’s Inhalable Insulin Fails to Get Approval for Trials on Indian Patients
06 Dec 2016 //
ECONOMIC TIMES
Indian pharma`s struggle to tighten standards paves way for M&A deals | Reuters
29 Jun 2015 //
DRUG REGULATIONS
SC ruling in Merck-Glenmark case should allay US pharma lobby concerns - Business Today
17 May 2015 //
DRUG REGULATIONS
